Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.245
-0.255 (-17.00%)
At close: Nov 15, 2024, 4:00 PM
1.450
+0.205 (16.47%)
After-hours: Nov 15, 2024, 6:40 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $74.96 million as of November 15, 2024. Its market cap has decreased by -24.89% in one year.
Market Cap
74.96M
Enterprise Value
52.05M
1-Year Change
-24.89%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $74.96M, a decrease of -61.26%. That is a compound annual growth rate of -12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 15, 2024 | 78.90M | -33.75% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 92.61M |
| HilleVax | 91.65M |
| Genenta Science | 91.45M |
| Werewolf Therapeutics | 91.35M |
| Protalix BioTherapeutics | 91.19M |
| Veru Inc. | 90.08M |
| Coherus BioSciences | 89.72M |
| P3 Health Partners | 89.39M |